Short communication · 4 Aug 2026
Conference abstractPublished 22 May 2017
Vasoactive effects of a new nitric oxide donating Acetylsalicylic derivative
University of Debrecen, Hungary
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aims: According to the latest WHO mortality rates, ischemic heart diseases within the cardiovascular diseases are the main cause of death among non-communicable diseases. In the following investigation, we have aimed to test the properties of a nitric oxide (NO) donating acetylsalicylic (ASA) derivative, which is newly synthesized, stable, and water soluble compound at the University of Debrecen, Hungary. Based on our hypothesis this molecule could combine the positive effects of the anticoagulant ASA and the vasodilator effect of NO, therefore, it could be a more powerful medication against ischemic heart diseases. Materials & Methods: In the first part of our experiments, we have aimed to test in vitro the possible cytotoxic effect of our ASA derivative on the MTT cell viability. H9c2 rat embryonic cardio myoblast cells were cultured in 10-4âÂ?Â?10-7 M containing medium. Next, we have measured the vasoactive effects on female Sprague Dawley rats ex vivo according to the Langendorff method in the presence or absence of the NO donating molecule. Results: Our newly synthesized NO donating ASA derivative did not affect the cell viability at the tested concentrations. Furthermore, we have noticed a dose-dependent vasodilatation was caused by our NO liberating compound. Discussion: Based on the beneficial observations through our experimental arrangement, the new molecule synthesized at our University is a powerful vasodilator with no significant toxic effects. It may contribute to new therapeutic approaches against ischemic heart diseases and possibly related syndromes, but the molecular mechanisms need to be clarified.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Attila Czompa”
- BylineArticles whose byline prints “Istvan Bak”
- BylineArticles whose byline prints “Istvan Lekli”
- BylineArticles whose byline prints “Aniko Borbas”
- BylineArticles whose byline prints “Pal Herczegh”
- BylineArticles whose byline prints “Arpad Tosaki”
